EMPAPHAGE L 25/5MG TAB

Empaphage L 25/5mg Tablet is a combination medication containing Empagliflozin and Linagliptin, designed for managing type 2 diabetes mellitus. Empagliflozin works by promoting glucose excretion through urine, while Linagliptin enhances insulin secretion in response to elevated blood sugar levels. This dual-action formulation helps achieve better glycemic control and may support cardiovascular health. Suitable for patients requiring combination therapy when monotherapy proves insufficient. Always use as directed by your healthcare provider.